Trump Pressures Kennedy to Cut Childhood Vaccine Schedule Amid Autism Rate Debate

What Happened

On May 2026, President Donald Trump reportedly asked Health and Human Services Secretary Robert F. Kennedy Jr. why he was not doing more to investigate the alleged link between vaccines and autism, according to people familiar with the matter cited by the Wall Street Journal. The conversation took place in a private setting and reflected Trump’s recurring focus on vaccine safety during his second term. The report notes that Trump ‘steers nearly every conversation with his health secretary back to the issue,’ indicating a persistent effort to shift HHS policy toward reducing childhood immunizations.

In response, Kennedy said he had been instructed to cool his vaccine‑skeptical stance ahead of the 2026 midterm elections, a claim that contradicts Trump’s direct urging. The disagreement highlights a tension within the administration over how aggressively to pursue vaccine‑related investigations.

What the Evidence Establishes

The Wall Street Journal report, sourced from individuals with knowledge of the discussions, establishes that Trump has repeatedly pressed Kennedy to examine vaccine safety concerns, specifically requesting action to lower the number of shots given to children. The article also cites Trump’s September 2025 press conference where he warned pregnant women against using acetaminophen (Tylenol) due to a claimed ‘very increased risk of autism,’ and referenced studies suggesting the Amish, who largely avoid vaccines, have no autism.

Separately, the source notes that under Trump’s leadership, the U.S. Centers for Disease Control and Prevention removed the coronavirus vaccine from the recommended immunization schedule for healthy children and pregnant women in 2025. Additionally, Kennedy announced the removal of a mercury‑based preservative from flu shots in the United States during the same year. As of 2020, the autism rate among 8‑year‑olds was 1 in 36; the source states that the rate has since worsened to 1 in 31 children as of the most recent data (presumably 2025).

Where the Accounts Conflict

The primary conflict centers on whether Kennedy was advised to suppress his vaccine‑skepticism before the midterms. Sources quoted by the Journal claim Kennedy had been told to ‘cool it’ on vaccines, while Trump’s alleged remarks directly urge him to prioritize the issue. This disagreement suggests differing internal messaging within the administration about the timing and intensity of vaccine‑related advocacy.

A second area of contention involves the scientific basis for the claimed autism‑vaccine link. Kennedy asserts that autism is an ‘environmental exposure’ and not genetic, citing rising rates and arguing that the increase is ‘catastrophic.’ Mainstream medical institutions, however, maintain that extensive research has found no causal relationship between vaccines and autism, and they attribute the observed rise in diagnoses to broader diagnostic criteria and increased awareness.

Finally, the Trump administration’s claim that unvaccinated groups such as the Amish have zero autism is presented without supporting epidemiological data in the source, and independent studies have not confirmed such a absolute absence of autism in any population.

Context and Stakes

The debate occurs amid a documented rise in autism spectrum disorder diagnoses, which the source notes increased from 1 in 36 in 2020 to 1 in 31 in the most recent year (2025). This trend has fueled public concern and political discourse about potential environmental contributors, including vaccines. The current childhood vaccine schedule requires infants to receive over a dozen doses in the first six months, with annual flu and coronavirus shots potentially bringing the total to upwards of 72 injections by age 18.

From a financial perspective, the article references Kennedy’s comment that autism adds to ‘already astronomical healthcare costs,’ implying that any perceived link between vaccines and autism could influence federal spending on special education, medical treatments, and disability benefits. A reduction in the recommended vaccine schedule could lower immediate procurement costs for the federal government but might also raise long‑term public‑health expenses if vaccine‑preventable disease outbreaks occur.

Politically, the push aligns with Trump’s broader effort to challenge established public‑health guidance, a stance that could energize his base ahead of the 2026 midterm elections while prompting opposition from medical associations, state health agencies, and international bodies such as the World Health Organization.

What to Watch Next

Observers should monitor whether the Department of Health and Human Services issues an updated childhood immunization schedule in the coming months, potentially reducing the number of recommended doses for diseases such as measles, mumps, rubella, polio, or hepatitis B. Any such revision would likely trigger a notice‑and‑comment period and could face legal challenges from advocacy groups claiming violation of the Public Health Service Act.

Additionally, the results of Kennedy’s announced series of studies to identify ‘precisely what environmental toxins’ are causing autism will be scrutinized for methodological rigor and peer‑review validation. Preliminary findings are expected within six to nine months, and their reception will shape the administration’s next steps on vaccine policy.

Public reaction, including statements from the American Academy of Pediatrics, the Centers for Disease Control and Prevention, and state‑level health departments, will be a key indicator of whether the administration’s pressure translates into concrete policy change or remains a rhetorical position without regulatory impact.

Bottom Line

The available evidence shows that President Trump is actively urging HHS Secretary Robert F. Kennedy Jr. to pursue a reduction in the number of vaccines recommended for children, citing rising autism rates and asserting that certain unvaccinated communities experience no autism. The Wall Street Journal report, based on sources familiar with private conversations, establishes that this pressure has been recurring since at least May 2026 and contradicts claims that Kennedy was told to downplay vaccine‑skepticism ahead of the midterms.

While the administration frames the initiative as a response to a growing public‑health crisis, the scientific consensus remains that vaccines do not cause autism, and the claimed autism‑free status of groups like the Amish lacks robust epidemiological support. The outcome will hinge on whether HHS alters the federal vaccine schedule, how the administration, schedule, and what independent research concludes about environmental contributors to autism.